Delivery Order SPE2DB20D2014-SPE2DB25FB63Z
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $278,847.16, is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $21,075.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the procurement of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication, to support military healthcare programs. As a general...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,938.51 firm fixed price delivery order is for the supply of the specialty medication Rebif 44 mcg/0.5 ml syringe, with a completion date of December 27, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $4,101.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC), covers the provision of REBIF SYR 0.5ML 12S, a pharmaceutical product. The contract has a firm fixed price and is set to run until November 13, 2024. While the original solicitation is not provided, the contract appears to be part of a...
This federal contract award, with a ceiling value of $4,410.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the pharmaceutical product Rebif Rebidose 44 mcg/0.5 ml, a multiple sclerosis medication. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent company, Cencora,...
This federal contract award is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $12,154.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 3, 2024 with a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $35,268.40 delivery order contract is for the supply of Rebif 44 mcg/0.5 mL syringes, a multiple sclerosis medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
The federal contract award is for the delivery of Rebif Rebidose 44 mcg/0.5 ml medication, with a ceiling value of $4,103.33. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award (SPE2DX15D1053|SPE2DX24F6PJJ) from the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4565005279 - REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has a ceiling value of $13,462.68 and is a firm fixed price delivery order that runs through June 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor registered in SAM.gov...
This federal contract award, with an ID of SPE2DB20D3103 and SPE2DB22FP1W2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,466.06 firm fixed-price delivery order is for the supply of 4557782755 - REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, with a completion date of July 14, 2022. This contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug...